HBK Investments’s Impax Laboratories, Inc. IPXL Stock Holding History

HBK Investments’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-6,300	Closed	-$269K	–	1206
2015 Q4	$269K	Sell	6,300 -6,023	-49%	-$241K	﹤0.01%	881
2015 Q3	$434K	Buy	+12,323	New	+$555K	﹤0.01%	785
2015 Q1	–	Sell	-12,300	Closed	-$390K	–	1242
2014 Q4	$390K	Buy	12,300 +1,744	+17%	+$51K	﹤0.01%	790
2014 Q3	$250K	Buy	+10,556	New	+$270K	﹤0.01%	870
2014 Q2	–	Sell	-32,100	Closed	-$848K	–	1106
2014 Q1	$848K	Buy	+32,100	New	+$802K	0.02%	538
2013 Q4	–	Sell	-15,486	Closed	-$318K	–	1071
2013 Q3	$318K	Sell	15,486 -23,014	-60%	-$475K	﹤0.01%	735
2013 Q2	$768K	Buy	+38,500	New	+$683K	0.01%	469

Other funds holding IPXL

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Hound Partners New York $799M AUM 9.54% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Aravt Global New York $11.3M AUM 3.78% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PCM

Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

HBK Investments's IPXL Position: Q1 2016 in Review

HBK Investments sold out of Impax Laboratories, Inc. (IPXL) in Q1 2016, closing a stake of 6,300 shares — an estimated $269K sold.

HBK Investments first reported a position in IPXL in Q2 2013 and held it in 7 quarters. The position peaked at $848K in Q1 2014. 194 funds tracked by Wall St. Rank hold IPXL as of Q1 2016.

HBK Investments reported no remaining Impax Laboratories, Inc. position as of Q1 2016 after selling out during the quarter.
HBK Investments sold 6,300 Impax Laboratories, Inc. shares in Q1 2016, an estimated $269K.
HBK Investments first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 7 quarters.
HBK Investments's Impax Laboratories, Inc. position peaked at $848K in Q1 2014.
194 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q1 2016.

Based on HBK Investments's 13F filing for Q1 2016, filed 13 May 2016.